Drug Cos. Rip Bid To Merge Lipitor, Effexor Antitrust Appeals

By Aaron Vehling (April 17, 2015, 4:46 PM EDT) -- Pfizer Inc. and Ranbaxy Inc. on Thursday urged the Third Circuit to reject a bid by Rite Aid Corp., Walgreen Co. and other retailers to consolidate all pending appeals in the Lipitor and Effexor XP pay-for-delay litigations, saying the cases are far too different to consolidate....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!